ScopusElsevier Scopus
Status
Inactive/Discontinued
Coverage
1954–1965
Source type
Journal
Open access
No
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Antibiotica et chemotherapia. Fortschritte. Advances. Progrès
Antibiotica et chemotherapia. Fortschritte. Advances. Progrès is not currently indexed in Scopus. Published by S. Karger AG.
ISSN 0376-0227Verify ISSN ↗
Publisher: S. Karger AG
Scopus · Inactive
0
Indexed in
major indexes
Cost to publish: No APC data — check the publisher
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Not listed in Web of Science.
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Is Antibiotica et chemotherapia. Fortschritte. Advances. Progrès indexed in Scopus? No — it was previously covered by Scopus but its coverage is now inactive/discontinued (1954–1965).
What is the impact factor of Antibiotica et chemotherapia. Fortschritte. Advances. Progrès? Antibiotica et chemotherapia. Fortschritte. Advances. Progrès has no Journal Impact Factor — JIF is published only for Web of Science SCIE and SSCI titles — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Is Antibiotica et chemotherapia. Fortschritte. Advances. Progrès in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Antibiotica et chemotherapia. Fortschritte. Advances. Progrès open access? No — it is not registered as an open-access journal in DOAJ or Scopus.
Impact & reach — open metrics via OpenAlex
35
h-index
176
2-yr mean citations
241
i10-index
1,021
works indexed
7,792
total citations
Antibiotica et chemotherapia. Fortschritte. Advances. Progrès published 1 papers in 2025; its busiest recent year was 2015 with 963. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-09-24.
Integrity signals — indicators, not proof of misconduct
- Scopus statusInactive — coverage ended 1965
- Retracted papers None recorded
Retractions and authorship from OpenAlex; Scopus status from the Scopus source list. A signal marks something to look at more closely; it is not a finding against the journal.
Official sources & links
Related journals
- Antibiotics and Chemotherapy
- Applied Neurophysiology
- Audiology and Neurotology Scopus Q2 WoS SCIE
- Beitrage zu Infusionstherapie und klinische Ernahrung
- Beitrage zur Infusionstherapie = Contributions to infusion therapy
- Beiträge zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine
- Bibliotheca Haematologica
- Bibliotheca microbiologica
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.